ARSLAN, N. Et Al. 2016. Antimikrobiyal susceptibility of five antimicrobil agents in Helicobacter pylori clinical isolates. XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancerin conjunction with the EHMSG/EAGEN POSTGRADUATE COURSE ’Gastrointestinal Microbiota in Health and Disease: What is the current evidence? , (Germany), 158.

ARSLAN, N., AVCU, A., GÜLDAŞ, N., AYSAL AĞALAR, A., DEMİRAY GÜRBÜZ, E., becerikli, t., ... SOYTÜRK, M.(2016). Antimikrobiyal susceptibility of five antimicrobil agents in Helicobacter pylori clinical isolates . XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancerin conjunction with the EHMSG/EAGEN POSTGRADUATE COURSE ’Gastrointestinal Microbiota in Health and Disease: What is the current evidence? (pp.158). , Germany

ARSLAN, NAZLI Et Al. "Antimikrobiyal susceptibility of five antimicrobil agents in Helicobacter pylori clinical isolates," XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancerin conjunction with the EHMSG/EAGEN POSTGRADUATE COURSE ’Gastrointestinal Microbiota in Health and Disease: What is the current evidence?, Germany, 2016

ARSLAN, NAZLI Et Al. "Antimikrobiyal susceptibility of five antimicrobil agents in Helicobacter pylori clinical isolates." XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancerin conjunction with the EHMSG/EAGEN POSTGRADUATE COURSE ’Gastrointestinal Microbiota in Health and Disease: What is the current evidence? , Germany, pp.158, 2016

ARSLAN, N. Et Al. (2016) . "Antimikrobiyal susceptibility of five antimicrobil agents in Helicobacter pylori clinical isolates." XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancerin conjunction with the EHMSG/EAGEN POSTGRADUATE COURSE ’Gastrointestinal Microbiota in Health and Disease: What is the current evidence? , Germany, p.158.

@conferencepaper{conferencepaper, author={NAZLI ARSLAN Et Al. }, title={Antimikrobiyal susceptibility of five antimicrobil agents in Helicobacter pylori clinical isolates}, congress name={XXIXth International Workshop on Helicobacter and Microbiota in Inflammation and Cancerin conjunction with the EHMSG/EAGEN POSTGRADUATE COURSE ’Gastrointestinal Microbiota in Health and Disease: What is the current evidence?}, city={}, country={Germany}, year={2016}, pages={158} }